期刊文献+

谷氨酸脱羧酶抗体滴度与糖尿病患者胰岛功能关系的研究 被引量:2

Study of relationship between glutamic acid decarboxylase antibody titers and islet function of patients with diabetes
下载PDF
导出
摘要 目的探讨谷氨酸脱羧酶抗体(GAD-Ab)与糖尿病胰岛功能的关系及对胰岛功能衰减速度的影响。方法对比137例糖尿病患者的胰岛功能检查及谷氨酸脱羧酶抗体(GAD-Ab)筛查,比较谷氨酸脱羧酶抗体(GAD-Ab)阳性组12例与阴性组125例的发病年龄、体重指数、胰岛功能-C肽及糖化血红蛋白等指标,并进行1年追踪随访。结果①GAD-Ab阳性组发病年龄、体重指数明显低于阴性组(P<0.01);②空腹及餐后2 h C肽值较阴性组低(P<0.01),糖化血红蛋白(HbA1C)明显高于阴性组(P<0.01);③1年内GAD-Ab阳性者胰岛功能衰减明显,并与GAD-Ab滴度、发病年龄、体重指数及用药密切相关。结论对糖尿病患者进行GAD-Ab检测,能预测胰岛细胞损伤进展情况,有利于协助糖尿病的确切分型,对于GADA阳性者,尽早使用胰岛素强化治疗,可以减轻或延缓自身免疫性胰岛炎的进程,对于改善患者预后具有重要的临床意义。 Objective To explore the glutamic acid decarboxylase antibody (GAD-Ab) relationship with diabetes islet function and the effects on attenuation of islet function. Methods Compared 137 patients with diabetes islet function and glutamic acid decarboxylase antibody (GAD-Ab) screening, comparison of glutamic acid decarboxylase antibody (GAD-Ab) positive group of 12 cases with negative group of onset age, body mass index (bmi), 125 cases of pancreatic islet function, indexes of c-peptide and glycated hemoglobin, and 1 year of follow-up. Results (1)GAD onset age, body mass index-Ab positive group was obviously lower than negative group (P 〈 0.01). (2)The fasting and postprandial, 2 h C peptide value was lower than those of negative group (P 〈 0.01), glycosylated hemoglobin (HbA1C) was significantly higher than negative group (/9 〈 0.01). (3) One year GAD-Ab positive islet function attenuation, and GAD-Ab drops, onset age, body mass index, and closely related to drug use. Conclusion GAD-Ab detection in patients with diabetes, can predict the progress of the islet cell damage, is conducive to help diabetes segmentation model, indeed for GADA positie, early use of insulin intensive treatment, can reduce or delay the development of autoimmune insulitis, for im- proving the prognosis of patients has important clinical significance.
出处 《中国现代医生》 2013年第11期139-140,共2页 China Modern Doctor
关键词 谷氨酸脱羧酶抗体 糖尿病 胰岛功能 Glutamic acid decarboxylase antibody Diabetes Islet function
  • 相关文献

参考文献7

  • 1Grp L,Miettinen A,Grp PH,et al. Orang-specific autimmunity and HLA-DR antigens as markers for B-cell destrucitin in patients with tipe 1[ diabetes[J]. Diabetes, 1998,37( 1 ) :99-102.
  • 2李霞,黄干,颜湘,杨琳,周智广.成人隐匿性自身免疫糖尿病患者胰岛素抵抗与谷氨酸脱羧酶抗体滴度的关系[J].南方医科大学学报,2010,30(6):1247-1249. 被引量:9
  • 3Turner R,Stratton 1,Horton V,et al. UKPDS 25 autoantibodies to islet cell cytoplasm and glutamie acid decarboxylase for prediction of insulin requirement in type 2 diabetes[J], l.aneet, 1997,350( 12):88-93.
  • 4杨琳,周智广,黄干,颜湘,欧阳玲莉,伍汉文.LADA患者胰岛β细胞功能的前瞻性研究[J].中华内分泌代谢杂志,2003,19(4):263-266. 被引量:30
  • 5何君钦,林丽香,陈鸣钦.糖尿病患者谷氨酸脱羧酶自身抗体测定的临床意义[J].中华内分泌代谢杂志,1997,13(2):97-100. 被引量:16
  • 6Kohayashi T, Nakanishi K, Murase Y ,et al. Small doses of subcutaneous insulin as a strategy for prewmting slowly progressive betacell lailure in islet cell antibodypositivc patients with clinical features of NIDDM[J]. Diabetes, 1996,45(6) :622.
  • 7Kobayashi T,Mauyama T,Schimada A,el al. Insulin in tervention to preserve beta cells in slowly progressiveinsu lin dependent (type 1) diabetes mellitus[J]. Ann NY Acad Sci ,2002,958(30) : 117.

二级参考文献19

  • 1王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 2Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease [J]. Diabetes, 1993, 42(2): 359-62.
  • 3Zimmet P, Turner R, McCarty D, et al. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes[J]. Diabetes Care, 1999, 22 (Suppl 2): B59-64.
  • 4Li X, Zhou Z, Huang G, et al. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes [J]. Ann NY Aead Sci, 2004, 1037: 122-6.
  • 5Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling[J]. Diabetes Care, 2004, 27(6): 1487-95.
  • 6Zhou Z, Li X, Huang G, et al. Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA) [J]. Diabetes Metab Res Rev, 2005, 21(2): 203-8.
  • 7Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes, 1993,42:359-362.
  • 8Torn C, Landin-Olsson M, Lernmark A, et al. Prognostic factors for the course of β cell function in autoimmune diabetes. J Clin Endocrinol Metab, 2000,85:4619-4623.
  • 9Gottsater A, Landin-Olsson M, Lernmark A, et al. Glutamate decarboxylase antibody level predicts rate of beta-cell decline in adult-onset diabetes. Diabetes Res Clin Pract, 1995,27:133-140.
  • 10Gardner SG, Gale EA, Williams AJ, et al. Progression to diabetes in relatives with islet autoantibdies. Is it inevitable? Diabetes Care, 1999,22:2049-2054.

共引文献52

同被引文献16

引证文献2

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部